CME Group Q3 Earnings Surpass Estimates, Revenues Rise Y/Y

Zacks
Zacks kaynağında aç
CME Group Q3 Earnings Surpass Estimates, Revenues Rise Y/Y

CME Group Inc. CME reported third-quarter 2026 adjusted earnings per share of $3.02, which beat the Zacks Consensus Estimate by 1.3%. The bottom line increased 12.7% year over year. 

Quarterly results reflected higher clearing and transaction fees, market data and information services, as well as higher trading volumes.

CME Group Inc. Price, Consensus and EPS Surprise

CME Group Inc. Price, Consensus and EPS Surprise

CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote

Performance in Detail

CME Group’s revenues of $1.73 billion increased 13% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees, market data and information services, and other factors. The top line beat the Zacks Consensus Estimate by 1.2%.

Total expenses rose 5.5% year over year to $595.9 million, attributable to higher technology, depreciation and amortization, licensing and other fee agreements, and other expenses.

Operating income increased 17.3% from the prior-year quarter to $1.14 billion.

Average daily volume (ADV) was a record 29.4 million contracts, up 16.3% year over year. ADV increased across Interest rates, Equity indexes, Foreign exchange, Energy, Agricultural commodities, and Metals product lines. The total average rate per contract was 67.9 cents.

Financial Update

As of Sept. 30, 2026, CME Group had $23.3 billion of cash and marketable securities, down 48.7% from the 2025-end level. As of Sept. 30, 2026, long-term debt was $3.4 billion, up 0.1% from 2025-end. As of Sept. 30, 2026, CME had shareholders' equity worth $26.5 billion, down 7.5% from the end of 2025.

Capital Deployment

CME Group paid out $1 billion in dividends during the third quarter of 2026, with $465 million in regular quarterly dividends and $524 million in share repurchases.

Zacks Rank

CME Group currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Upcoming Releases

Intercontinental Exchange Inc. ICE is set to report third-quarter 2026 results on Oct. 29, before market open. The Zacks Consensus Estimate for third-quarter earnings per share is pegged at $1.97, suggesting an increase of 15.2% from the year-ago quarter’s reported figure.

ICE’s earnings beat estimates in each of the last four quarters.

Cboe Global Markets, Inc. CBOE is set to report third-quarter 2026 results on Oct. 30, before market open. The Zacks Consensus Estimate for third-quarter earnings per share is pegged at $3.40, suggesting an increase of 27.3% from the year-ago quarter’s reported figure.

CBOE’s earnings beat estimates in each of the last four quarters.

Nasdaq, Inc. NDAQ is set to report third-quarter 2026 results on Oct. 22, before market open. The Zacks Consensus Estimate for third-quarter earnings per share is pegged at $1.02, suggesting an increase of 15.9% from the year-ago quarter’s reported figure.

NDAQ’s earnings beat estimates in each of the last four quarters.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
CME Group Inc. (CME): Free Stock Analysis Report
 
Intercontinental Exchange Inc. (ICE): Free Stock Analysis Report
 
Nasdaq, Inc. (NDAQ): Free Stock Analysis Report
 
Cboe Global Markets, Inc. (CBOE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research